These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17076637)

  • 21. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
    López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
    Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.
    Ozhak-Baysan B; Ongut G; Ogunc D; Gunseren F; Sepin-Ozen N; Ozturk F; Aktepe OC; Gultekin M
    Pol J Microbiol; 2010; 59(1):55-60. PubMed ID: 20568531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum.
    Celli J; de Chastellier C; Franchini DM; Pizarro-Cerda J; Moreno E; Gorvel JP
    J Exp Med; 2003 Aug; 198(4):545-56. PubMed ID: 12925673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes.
    Rittig MG; Alvarez-Martinez MT; Porte F; Liautard JP; Rouot B
    Infect Immun; 2001 Jun; 69(6):3995-4006. PubMed ID: 11349069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis.
    Billard E; Cazevieille C; Dornand J; Gross A
    Infect Immun; 2005 Dec; 73(12):8418-24. PubMed ID: 16299342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatments in the management of brucellosis.
    Pappas G; Akritidis N; Tsianos E
    Expert Opin Pharmacother; 2005 Feb; 6(2):201-9. PubMed ID: 15757417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brucellosis in Sub-Saharan Africa: Current challenges for management, diagnosis and control.
    Ducrotoy M; Bertu WJ; Matope G; Cadmus S; Conde-Álvarez R; Gusi AM; Welburn S; Ocholi R; Blasco JM; Moriyón I
    Acta Trop; 2017 Jan; 165():179-193. PubMed ID: 26551794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
    Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
    Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis.
    Navarro E; Segura JC; Castaño MJ; Solera J
    Clin Infect Dis; 2006 May; 42(9):1266-73. PubMed ID: 16586386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiological and microbiological study of brucellosis in Kuwait.
    Dimitrov Ts; Panigrahi D; Emara M; Awni F; Passadilla R
    Med Princ Pract; 2004; 13(4):215-9. PubMed ID: 15181327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case report of spontaneous abortion caused by Brucella melitensis biovar 3.
    Yang HX; Feng JJ; Zhang QX; Hao RE; Yao SX; Zhao R; Piao DR; Cui BY; Jiang H
    Infect Dis Poverty; 2018 May; 7(1):31. PubMed ID: 29716658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current therapeutical strategies in human brucellosis.
    Bosilkovski M; Keramat F; Arapović J
    Infection; 2021 Oct; 49(5):823-832. PubMed ID: 33650077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic persistence of intracellular Brucella abortus.
    Mode S; Ketterer M; Québatte M; Dehio C
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010635. PubMed ID: 35881641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The innate immune response against Brucella in humans.
    Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP
    Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brucella melitensis sternal osteomyelitis following median sternotomy.
    Chin YT; Krishnan M; Burns P; Qamruddin A; Hasan R; Dodgson AR
    J Infect Chemother; 2014 Sep; 20(9):574-6. PubMed ID: 24910374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of clinical and laboratory features of human brucellosis.
    Mantur BG; Amarnath SK; Shinde RS
    Indian J Med Microbiol; 2007 Jul; 25(3):188-202. PubMed ID: 17901634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the quantum dot-labeled solid lipid nanoparticles for delivery of streptomycin and hydroxychloroquine: A new therapeutic approach for treatment of intracellular Brucella abortus infection.
    Karimitabar Z; Chegini Z; Shokoohizadeh L; Moez NM; Arabestani MR; Hosseini SM
    Biomed Pharmacother; 2023 Feb; 158():114116. PubMed ID: 36527846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
    Prior S; Gander B; Lecároz C; Irache JM; Gamazo C
    J Antimicrob Chemother; 2004 Jun; 53(6):981-8. PubMed ID: 15102748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoniosome-encapsulated levoflaxicin as an antibacterial agent against Brucella.
    Khan S; Akhtar MU; Khan S; Javed F; Khan AA
    J Basic Microbiol; 2020 Mar; 60(3):281-290. PubMed ID: 31856360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central Nervous System Brucellosis Granuloma and White Matter Disease in Immunocompromised Patient.
    Alqwaifly M; Al-Ajlan FS; Al-Hindi H; Al Semari A
    Emerg Infect Dis; 2017 Jun; 23(6):978-981. PubMed ID: 28518039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.